{"transactions":[{"id":1524585,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-07T21:46:20.000Z","date":"2024-05-03","kind":"other","planned":false,"acquired":false,"shares":1785127,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 3, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 421,061 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 3, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 421,061 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). In such capacities, CPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4."}],"balance_after":2823681,"source":{"system":"sec-edgar","filing":"0000905148-24-001300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000090514824001300/form4.xml","form_type":"4"}},{"id":1772227,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":993929,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":993929},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772226,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":114946,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":114946},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772225,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1490,"ownership":{"direct":false,"nature":"By Redbird Life Sciences Partners, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772224,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":123279,"ownership":{"direct":false,"nature":"By CD Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":123279},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772223,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":307776,"ownership":{"direct":false,"nature":"By Kestrel Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":307776},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772222,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150186,"ownership":{"direct":false,"nature":"By Mallard Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":150186},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772221,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1251,"ownership":{"direct":false,"nature":"By CPMG, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":1251},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772220,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":134,"ownership":{"direct":false,"nature":"By Redbird Life Sciences Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772219,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11076,"ownership":{"direct":false,"nature":"By CD Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772218,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":160265,"ownership":{"direct":false,"nature":"By Kestrel Fund, LP("},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772217,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":334740,"ownership":{"direct":false,"nature":"By Sandpiper Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772216,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37909,"ownership":{"direct":false,"nature":"By Crested Crane, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772215,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":109415,"ownership":{"direct":false,"nature":"By Mallard Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772214,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":431155,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772213,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":748253,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772212,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":442560,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772211,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34897,"ownership":{"direct":false,"nature":"By Managed Account for Trustees of the University of Pennsylvania"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772210,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44200,"ownership":{"direct":false,"nature":"By Barred Owl Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772209,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5464,"ownership":{"direct":false,"nature":"By Elepaio Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772208,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":137962,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772207,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":282246,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772206,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":116512,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772205,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":113,"ownership":{"direct":false,"nature":"By CPMG, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772204,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31467,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1928986,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-05T00:13:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":400675,"ownership":{"direct":false,"nature":"By Mallard Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036123016439/form4.xml","form_type":"4"}},{"id":1928985,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-05T00:13:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":63671,"ownership":{"direct":false,"nature":"By Kestrel Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036123016439/form4.xml","form_type":"4"}},{"id":1928984,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-05T00:13:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45594,"ownership":{"direct":false,"nature":"By Crested Crane, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036123016439/form4.xml","form_type":"4"}},{"id":1928983,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-05T00:13:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3687781,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036123016439/form4.xml","form_type":"4"}},{"id":1928982,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-05T00:13:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1310701,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036123016439/form4.xml","form_type":"4"}},{"id":1928981,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-05T00:13:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":675181,"ownership":{"direct":false,"nature":"By Curlew Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the disposition of the Reporting Persons' indirectly owned shares of the Issuer's common stock, par value $0.001 per share (\"Issuer Common Stock\"), upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer Common Stock was canceled and converted automatically into the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036123016439/form4.xml","form_type":"4"}},{"id":2074407,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"6.0% Convertible Debentures due 2026","published_at":"2022-12-30T22:22:16.000Z","date":"2022-12-28","kind":"exercise","acquired":false,"price":0,"reported_value":4763750,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 28, 2022 (the \"Forced Conversion Date\"), the Issuer notified the holders of its outstanding 6.0% Convertible Debentures due 2026 (the \"Debentures\") that it elected to cause the eligible portion of the aggregate principal amount of the Debentures outstanding to be converted into shares of the Issuer's common stock at the fixed conversion price of $3.25 per share and to issue shares of the Issuer's common stock to satisfy accrued but unpaid interest on the principal amount to be converted through the Forced Conversion Date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":3.25,"exercise_date":"2019-08-12","expiration_date":"2026-08-12","underlying":"Common Stock","underlying_shares":1465770},"source":{"system":"sec-edgar","filing":"0001140361-22-047713","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036122047713/form4.xml","form_type":"4"}},{"id":2074406,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"6.0% Convertible Debentures due 2026","published_at":"2022-12-30T22:22:16.000Z","date":"2022-12-28","kind":"exercise","acquired":false,"price":0,"reported_value":1905500,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 28, 2022 (the \"Forced Conversion Date\"), the Issuer notified the holders of its outstanding 6.0% Convertible Debentures due 2026 (the \"Debentures\") that it elected to cause the eligible portion of the aggregate principal amount of the Debentures outstanding to be converted into shares of the Issuer's common stock at the fixed conversion price of $3.25 per share and to issue shares of the Issuer's common stock to satisfy accrued but unpaid interest on the principal amount to be converted through the Forced Conversion Date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":3.25,"exercise_date":"2019-08-12","expiration_date":"2026-08-12","underlying":"Common Stock","underlying_shares":586308},"source":{"system":"sec-edgar","filing":"0001140361-22-047713","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036122047713/form4.xml","form_type":"4"}},{"id":2074405,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"6.0% Convertible Debentures due 2026","published_at":"2022-12-30T22:22:16.000Z","date":"2022-12-28","kind":"exercise","acquired":false,"price":0,"reported_value":476375,"ownership":{"direct":false,"nature":"By Curlew Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 28, 2022 (the \"Forced Conversion Date\"), the Issuer notified the holders of its outstanding 6.0% Convertible Debentures due 2026 (the \"Debentures\") that it elected to cause the eligible portion of the aggregate principal amount of the Debentures outstanding to be converted into shares of the Issuer's common stock at the fixed conversion price of $3.25 per share and to issue shares of the Issuer's common stock to satisfy accrued but unpaid interest on the principal amount to be converted through the Forced Conversion Date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":3.25,"exercise_date":"2019-08-12","expiration_date":"2026-08-12","underlying":"Common Stock","underlying_shares":146577},"source":{"system":"sec-edgar","filing":"0001140361-22-047713","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036122047713/form4.xml","form_type":"4"}},{"id":2074404,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2022-12-30T22:22:16.000Z","date":"2022-12-28","kind":"exercise","acquired":true,"shares":1465770,"price":3.25,"value":4763752.5,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 28, 2022 (the \"Forced Conversion Date\"), the Issuer notified the holders of its outstanding 6.0% Convertible Debentures due 2026 (the \"Debentures\") that it elected to cause the eligible portion of the aggregate principal amount of the Debentures outstanding to be converted into shares of the Issuer's common stock at the fixed conversion price of $3.25 per share and to issue shares of the Issuer's common stock to satisfy accrued but unpaid interest on the principal amount to be converted through the Forced Conversion Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"This amount includes an aggregate 70,802 shares issued by the Issuer to the Roadrunner Fund, LP since the last Form 4 filed by the Reporting Person on October 19, 2021, including 56,598 shares paid in the semi-annual interest payments in January 2022 and in July 2022, and 14,204 shares paid on accrued but unpaid interest through the Forced Conversion Date, on the Debentures held by the Roadrunner Fund, LP, which transactions were exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9(a)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":3687781,"source":{"system":"sec-edgar","filing":"0001140361-22-047713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036122047713/form4.xml","form_type":"4"}},{"id":2074403,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2022-12-30T22:22:16.000Z","date":"2022-12-28","kind":"exercise","acquired":true,"shares":586308,"price":3.25,"value":1905501.0,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 28, 2022 (the \"Forced Conversion Date\"), the Issuer notified the holders of its outstanding 6.0% Convertible Debentures due 2026 (the \"Debentures\") that it elected to cause the eligible portion of the aggregate principal amount of the Debentures outstanding to be converted into shares of the Issuer's common stock at the fixed conversion price of $3.25 per share and to issue shares of the Issuer's common stock to satisfy accrued but unpaid interest on the principal amount to be converted through the Forced Conversion Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This amount includes an aggregate 28,322 shares issued by the Issuer to the Killdeer Fund, LP since the last Form 4 filed by the Reporting Person on October 19, 2021, including 22,640 shares paid in the semi-annual interest payments in January 2022 and in July 2022, and 5,682 shares paid on accrued but unpaid interest through the Forced Conversion Date, on the Debentures held by the Killdeer Fund, LP, which transactions were exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9(a)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":1310701,"source":{"system":"sec-edgar","filing":"0001140361-22-047713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036122047713/form4.xml","form_type":"4"}},{"id":2074402,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":2,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2022-12-30T22:22:16.000Z","date":"2022-12-28","kind":"exercise","acquired":true,"shares":146577,"price":3.25,"value":476375.25,"ownership":{"direct":false,"nature":"By Curlew Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 28, 2022 (the \"Forced Conversion Date\"), the Issuer notified the holders of its outstanding 6.0% Convertible Debentures due 2026 (the \"Debentures\") that it elected to cause the eligible portion of the aggregate principal amount of the Debentures outstanding to be converted into shares of the Issuer's common stock at the fixed conversion price of $3.25 per share and to issue shares of the Issuer's common stock to satisfy accrued but unpaid interest on the principal amount to be converted through the Forced Conversion Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount includes an aggregate 7,082 shares issued by the Issuer to the Curlew Fund, LP since the last Form 4 filed by the Reporting Person on October 19, 2021, including 5,661 shares paid in the semi-annual interest payments in January 2022 and in July 2022, and 1,421 shares paid on accrued but unpaid interest through the Forced Conversion Date, on the Debentures held by the Curlew Fund, LP, which transactions were exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9(a)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares held directly by the Funds. Kent McGaughy, Jr. reports his beneficial ownership of these shares on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":675181,"source":{"system":"sec-edgar","filing":"0001140361-22-047713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000114036122047713/form4.xml","form_type":"4"}},{"id":2093192,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-12-07T16:32:31.000Z","date":"2022-12-05","kind":"other","acquired":false,"shares":1726534,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 5, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 236,734 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 5, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 236,734 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P., and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). In such capacities, CPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4."}],"balance_after":5029869,"source":{"system":"sec-edgar","filing":"0001140361-22-044739","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000114036122044739/form4.xml","form_type":"4"}},{"id":2114398,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-11-16T16:31:04.000Z","date":"2022-11-14","kind":"other","acquired":false,"shares":1729482,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On November 14, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 233,056 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 233,056 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P., and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). In such capacities,\nCPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and\nmanaging partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares\nbeneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4."}],"balance_after":6993137,"source":{"system":"sec-edgar","filing":"0001140361-22-041922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000114036122041922/form4.xml","form_type":"4"}},{"id":2160090,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-09-13T16:45:48.000Z","date":"2022-09-09","kind":"other","acquired":false,"shares":986640,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 9, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 133,176 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 9, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 133,176 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and the investment manager of each of Kestrel Fund, L.P. and Mallard Fund, L.P. (together with White Tailed Ptarmigan, LP, the \"CPMG Funds\").  In such capacities, CPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds.  Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4."}],"balance_after":8955675,"source":{"system":"sec-edgar","filing":"0001140361-22-033193","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000114036122033193/form4.xml","form_type":"4"}},{"id":2163164,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-09-08T16:46:04.000Z","date":"2022-09-06","kind":"other","acquired":false,"shares":743021,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 6, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 99,881 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 6, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 99,881 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and the investment manager of each of Kestrel Fund, L.P. and Mallard Fund, L.P. (together with White Tailed Ptarmigan, LP, the \"CPMG Funds\"). In such capacities, CPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4."}],"balance_after":10075491,"source":{"system":"sec-edgar","filing":"0001140361-22-032770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000114036122032770/form4.xml","form_type":"4"}},{"id":2322994,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"ten_percent_owner":true}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-03-21T18:22:17.000Z","date":"2022-03-17","kind":"other","acquired":false,"shares":304268,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"White Tailed Ptarmigan, LP distributed these shares to one of its partners on a pro rata basis, for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":10918394,"source":{"system":"sec-edgar","filing":"0001140361-22-010390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000114036122010390/form4.xml","form_type":"4"}},{"id":2538945,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2021-10-19T18:43:38.000Z","date":"2021-10-15","kind":"purchase","acquired":true,"shares":387097,"price":7.75,"value":3000001.75,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired in an underwritten registered follow-on offering by the Issuer that closed on October 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were acquired in an underwritten registered follow-on offering by the Issuer that closed on October 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This amount includes an aggregate 56,904 shares issued by the Issuer to the Roadrunner Fund, LP since the last Form 4 filed by the Reporting Person on July 21, 2020, as the semi-annual interest payments, in January 2021 and in July 2021, on the 6.0% Convertible Debentures due 2024 held by the Roadrunner Fund, LP, which transactions were exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9(a)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, the Reporting Person may be deemed to exercise voting and investment control over the securities owned by each of the Funds. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, the Reporting Person may be deemed to exercise voting and investment control over the securities owned by each of the Funds. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":2151209,"source":{"system":"sec-edgar","filing":"0001140361-21-034927","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000114036121034927/form4.xml","form_type":"4"}},{"id":2538944,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2021-10-19T18:43:38.000Z","date":"2021-10-15","kind":"purchase","acquired":true,"shares":258064,"price":7.75,"value":1999996.0,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired in an underwritten registered follow-on offering by the Issuer that closed on October 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were acquired in an underwritten registered follow-on offering by the Issuer that closed on October 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amount includes an aggregate 22,763 shares issued by the Issuer to the Killdeer Fund, LP since the last Form 4 filed by the Reporting Person on July 21, 2020, as the semi-annual interest payments, in January 2021 and in July 2021, on the 6.0% Convertible Debentures due 2024 held by the Killdeer Fund, LP, which transactions were exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9(a)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, the Reporting Person may be deemed to exercise voting and investment control over the securities owned by each of the Funds. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, the Reporting Person may be deemed to exercise voting and investment control over the securities owned by each of the Funds. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":696071,"source":{"system":"sec-edgar","filing":"0001140361-21-034927","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000114036121034927/form4.xml","form_type":"4"}},{"id":2538943,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2021-10-19T18:43:38.000Z","date":"2021-10-15","kind":"purchase","acquired":true,"shares":38710,"price":7.75,"value":300002.5,"ownership":{"direct":false,"nature":"By Curlew Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired in an underwritten registered follow-on offering by the Issuer that closed on October 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were acquired in an underwritten registered follow-on offering by the Issuer that closed on October 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes an aggregate 5,692 shares issued by the Issuer to the Curlew Fund, LP since the last Form 4 filed by the Reporting Person on July 21, 2020, as the semi-annual interest payments, in January 2021 and in July 2021, on the 6.0% Convertible Debentures due 2024 held by the Curlew Fund, LP, which transactions were exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9(a)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, the Reporting Person may be deemed to exercise voting and investment control over the securities owned by each of the Funds. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP (the \"Funds\"). In such capacity, the Reporting Person may be deemed to exercise voting and investment control over the securities owned by each of the Funds. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":521522,"source":{"system":"sec-edgar","filing":"0001140361-21-034927","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000114036121034927/form4.xml","form_type":"4"}},{"id":2562998,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series G Convertible Preferred Stock","published_at":"2021-09-21T18:34:24.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":272205,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":272205},"source":{"system":"sec-edgar","filing":"0001628280-21-018953","document":"wf-form4_163226365231972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000162828021018953/wf-form4_163226365231972.xml","form_type":"4"}},{"id":2562997,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2021-09-21T18:34:24.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":2060802,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2060802},"source":{"system":"sec-edgar","filing":"0001628280-21-018953","document":"wf-form4_163226365231972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000162828021018953/wf-form4_163226365231972.xml","form_type":"4"}},{"id":2562996,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2021-09-21T18:34:24.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":3038934,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3038934},"source":{"system":"sec-edgar","filing":"0001628280-21-018953","document":"wf-form4_163226365231972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000162828021018953/wf-form4_163226365231972.xml","form_type":"4"}},{"id":2562995,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2021-09-21T18:34:24.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":4712969,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4712969},"source":{"system":"sec-edgar","filing":"0001628280-21-018953","document":"wf-form4_163226365231972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000162828021018953/wf-form4_163226365231972.xml","form_type":"4"}},{"id":2562994,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T18:34:24.000Z","date":"2021-09-17","kind":"purchase","acquired":true,"shares":440000,"price":25,"value":11000000.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a purchase in the Issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":11222662,"source":{"system":"sec-edgar","filing":"0001628280-21-018953","document":"wf-form4_163226365231972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000162828021018953/wf-form4_163226365231972.xml","form_type":"4"}},{"id":2562993,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":2,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91373,"kind":"organization","name":"White Tailed Ptarmigan, LP","position":3,"cik":"0001882743","reported_name":"White Tailed Ptarmigan, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T18:34:24.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":10084910,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and has voting and investment control over the shares beneficially owned by White Tailed Ptarmigan, LP. Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein. Antal Desai is separately reporting his deemed indirect ownership of the shares held by White Tailed Ptarmigan, LP."}],"balance_after":10782662,"source":{"system":"sec-edgar","filing":"0001628280-21-018953","document":"wf-form4_163226365231972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000162828021018953/wf-form4_163226365231972.xml","form_type":"4"}},{"id":2930004,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-12-29T17:35:55.000Z","date":"2020-12-23","kind":"other","acquired":false,"shares":103185,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction represents the revocation of the Reporting Person's investment discretion with respect to the shares held by the Blackwell Account. No distribution or sale of shares was made by the Reporting Person in connection with the transaction.  The transaction reflects 2.2% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction represents the revocation of the Reporting Person's investment discretion with respect to the shares held by the Blackwell Account. No distribution or sale of shares was made by the Reporting Person in connection with the transaction.  The transaction reflects 2.2% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The transaction represents the revocation of the Reporting Person's investment discretion with respect to the shares held by the Blackwell Account. No distribution or sale of shares was made by the Reporting Person in connection with the transaction.  The transaction reflects 2.2% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania and a managed account of Blackwell Partners LLC - Series A (the \"Blackwell Account\"). The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania and a managed account of Blackwell Partners LLC - Series A (the \"Blackwell Account\"). The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-20-029804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036120029804/form4.xml","form_type":"4"}},{"id":2930003,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-12-29T17:35:55.000Z","date":"2020-12-23","kind":"other","acquired":false,"shares":63481,"ownership":{"direct":false,"nature":"By Flamingo Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction represents the distribution of shares by Flamingo Fund, LP to its sole limited partner. No sale of shares was made by the Reporting Person or Flamingo Fund, LP in connection with the transaction. The transaction reflects 1.3% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction represents the distribution of shares by Flamingo Fund, LP to its sole limited partner. No sale of shares was made by the Reporting Person or Flamingo Fund, LP in connection with the transaction. The transaction reflects 1.3% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The transaction represents the distribution of shares by Flamingo Fund, LP to its sole limited partner. No sale of shares was made by the Reporting Person or Flamingo Fund, LP in connection with the transaction. The transaction reflects 1.3% of the 4,756,424 Class A and Class B shares of the issuer beneficially owned by the Reporting Person prior to the date of the transaction."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania and a managed account of Blackwell Partners LLC - Series A (the \"Blackwell Account\"). The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania and a managed account of Blackwell Partners LLC - Series A (the \"Blackwell Account\"). The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-20-029804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036120029804/form4.xml","form_type":"4"}},{"id":3078628,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-07-21T18:39:08.000Z","date":"2020-07-17","kind":"purchase","acquired":true,"shares":1200000,"price":1.25,"value":1500000.0,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired directly from the Issuer pursuant to a securities purchase agreement dated as of July 17, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were acquired directly from the Issuer pursuant to a securities purchase agreement dated as of July 17, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1707208,"source":{"system":"sec-edgar","filing":"0000905148-20-000825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000090514820000825/form4.xml","form_type":"4"}},{"id":3078627,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-07-21T18:39:08.000Z","date":"2020-07-17","kind":"purchase","acquired":true,"shares":400000,"price":1.25,"value":500000.0,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired directly from the Issuer pursuant to a securities purchase agreement dated as of July 17, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were acquired directly from the Issuer pursuant to a securities purchase agreement dated as of July 17, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":415244,"source":{"system":"sec-edgar","filing":"0000905148-20-000825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000090514820000825/form4.xml","form_type":"4"}},{"id":3078626,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-07-21T18:39:08.000Z","date":"2020-07-17","kind":"purchase","acquired":true,"shares":180000,"price":1.25,"value":225000.0,"ownership":{"direct":false,"nature":"By Curlew Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired directly from the Issuer pursuant to a securities purchase agreement dated as of July 17, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were acquired directly from the Issuer pursuant to a securities purchase agreement dated as of July 17, 2020."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":477120,"source":{"system":"sec-edgar","filing":"0000905148-20-000825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000090514820000825/form4.xml","form_type":"4"}},{"id":3317832,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-01-06T18:27:28.000Z","date":"2020-01-02","kind":"other","acquired":true,"shares":38108,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Issuer's 6.0% Convertible Debentures due 2024 (\"Notes\"), the semi-annual interest payment due on the Notes was paid by the Issuer in shares of the Issuer's common stock, based on the interest rate of 6.00% per year and the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the interest payment date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Issuer's 6.0% Convertible Debentures due 2024 (\"Notes\"), the semi-annual interest payment due on the Notes was paid by the Issuer in shares of the Issuer's common stock, based on the interest rate of 6.00% per year and the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the interest payment date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":507208,"source":{"system":"sec-edgar","filing":"0001140361-20-000329","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000114036120000329/form4.xml","form_type":"4"}},{"id":3317831,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-01-06T18:27:28.000Z","date":"2020-01-02","kind":"other","acquired":true,"shares":15244,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Issuer's 6.0% Convertible Debentures due 2024 (\"Notes\"), the semi-annual interest payment due on the Notes was paid by the Issuer in shares of the Issuer's common stock, based on the interest rate of 6.00% per year and the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the interest payment date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Issuer's 6.0% Convertible Debentures due 2024 (\"Notes\"), the semi-annual interest payment due on the Notes was paid by the Issuer in shares of the Issuer's common stock, based on the interest rate of 6.00% per year and the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the interest payment date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15244,"source":{"system":"sec-edgar","filing":"0001140361-20-000329","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000114036120000329/form4.xml","form_type":"4"}},{"id":3317830,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2020-01-06T18:27:28.000Z","date":"2020-01-02","kind":"other","acquired":true,"shares":3811,"ownership":{"direct":false,"nature":"By Curlew Fund, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Issuer's 6.0% Convertible Debentures due 2024 (\"Notes\"), the semi-annual interest payment due on the Notes was paid by the Issuer in shares of the Issuer's common stock, based on the interest rate of 6.00% per year and the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the interest payment date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Issuer's 6.0% Convertible Debentures due 2024 (\"Notes\"), the semi-annual interest payment due on the Notes was paid by the Issuer in shares of the Issuer's common stock, based on the interest rate of 6.00% per year and the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the interest payment date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Crested Crane, LP; Curlew Fund, LP; Kestrel Fund, LP; Mallard Fund, LP; Roadrunner Fund, LP; and Killdeer Fund, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":297120,"source":{"system":"sec-edgar","filing":"0001140361-20-000329","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251769/000114036120000329/form4.xml","form_type":"4"}},{"id":3367893,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-11-18T17:20:16.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":5464,"price":183,"value":999912.0,"ownership":{"direct":false,"nature":"By Elepaio Partners, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":5464,"source":{"system":"sec-edgar","filing":"0000905148-19-001001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/form4.xml","form_type":"4"}},{"id":3367892,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-11-18T17:20:16.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":27322,"price":183,"value":4999926.0,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":137962,"source":{"system":"sec-edgar","filing":"0000905148-19-001001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/form4.xml","form_type":"4"}},{"id":3367891,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-11-18T17:20:16.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":328,"price":183,"value":60024.0,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":282246,"source":{"system":"sec-edgar","filing":"0000905148-19-001001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/form4.xml","form_type":"4"}},{"id":3367890,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-11-18T17:20:16.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":7104,"price":183,"value":1300032.0,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Killdeer Fund, LP; Willet Fund, LP; Elepaio Partners, LP; Barred Owl Partners, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":116512,"source":{"system":"sec-edgar","filing":"0000905148-19-001001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514819001001/form4.xml","form_type":"4"}},{"id":3733767,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2018-12-12T17:57:55.000Z","date":"2018-12-12","kind":"purchase","acquired":true,"shares":1418,"price":59.8952,"value":84931.3936,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This price reflects the weighted average purchase price for open-market purchases on December 12, 2018, within a $1.00 range.  The actual prices for these transactions range from $59.84 to $59.98, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":281918,"source":{"system":"sec-edgar","filing":"0000905148-18-000920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/form4.xml","form_type":"4"}},{"id":3733766,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2018-12-12T17:57:55.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":52809,"price":60.0719,"value":3172336.9671,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This price reflects the weighted average purchase price for open-market purchases on December 11, 2018, within a $1.00 range.  The actual prices for these transactions range from $59.52 to $60.145, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":109408,"source":{"system":"sec-edgar","filing":"0000905148-18-000920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/form4.xml","form_type":"4"}},{"id":3733765,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2018-12-12T17:57:55.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":29347,"price":59.5303,"value":1747035.7141,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price reflects the weighted average purchase price for open-market purchases on December 10, 2018, within a $1.00 range.  The actual prices for these transactions range from $59.24 to $59.80, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":56599,"source":{"system":"sec-edgar","filing":"0000905148-18-000920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/form4.xml","form_type":"4"}},{"id":3733764,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2018-12-12T17:57:55.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":1078,"price":58.6218,"value":63194.3004,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average purchase price for open-market purchases on December 10, 2018, within a $1.00 range.  The actual prices for these transactions range from $58.235 to $59.17, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":27252,"source":{"system":"sec-edgar","filing":"0000905148-18-000920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/form4.xml","form_type":"4"}},{"id":3733763,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2018-12-12T17:57:55.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":26174,"price":57.9329,"value":1516335.7246,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 10, 2018, within a $1.00 range.  The actual prices for these transactions range from $57.235 to $58.23, inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":26174,"source":{"system":"sec-edgar","filing":"0000905148-18-000920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514818000920/form4.xml","form_type":"4"}},{"id":4118852,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-29T17:03:01.000Z","date":"2017-12-29","kind":"purchase","acquired":true,"shares":17000,"price":28.4715,"value":484015.5,"ownership":{"direct":false,"nature":"By Barred Owl Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 29, 2017, within a $1.00 range.  The actual prices for these transactions range from $28.40 to $28.50 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":44200,"source":{"system":"sec-edgar","filing":"0001140361-17-047821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047821/form4.xml","form_type":"4"}},{"id":4120018,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-28T18:53:46.000Z","date":"2017-12-28","kind":"purchase","acquired":true,"shares":200,"price":26.1,"value":5220.0,"ownership":{"direct":false,"nature":"By Barred Owl Partners, LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":27200,"source":{"system":"sec-edgar","filing":"0001140361-17-047647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047647/form4.xml","form_type":"4"}},{"id":4120017,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-28T18:53:46.000Z","date":"2017-12-27","kind":"purchase","acquired":true,"shares":15000,"price":25.8296,"value":387444.0,"ownership":{"direct":false,"nature":"By Barred Owl Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 27, 2017, within a $1.00 range.  The actual prices for these transactions range from $25.595 to $26.00 inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001140361-17-047647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047647/form4.xml","form_type":"4"}},{"id":4120016,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-28T18:53:46.000Z","date":"2017-12-26","kind":"purchase","acquired":true,"shares":12000,"price":26.0605,"value":312726.0,"ownership":{"direct":false,"nature":"By Barred Owl Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 26, 2017, within a $1.00 range.  The actual prices for these transactions range from $25.72 to $26.14 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the investment manager of each of: Barred Owl Partners, LP; Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001140361-17-047647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047647/form4.xml","form_type":"4"}},{"id":4120015,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-28T18:38:57.000Z","date":"2017-12-14","kind":"purchase","acquired":true,"shares":14866,"price":24.6528,"value":366488.5248,"ownership":{"direct":false,"nature":"By Managed Account for Trustees of the University of Pennsylvania"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On December 15, 2017, the Reporting Persons inadvertently reported that these shares were purchased for the account of Gallopavo, LP.  As correctly noted on this amendment, the shares were purchased for a managed account for Trustees of the University of Pennsylvania.  Gallopavo, LP has not engaged in trades since the report filed by the Reporting Persons on June 23, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range.  The actual prices for these transactions range from $24.40 to $24.92, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":34897,"source":{"system":"sec-edgar","filing":"0001140361-17-047643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047643/form4.xml","form_type":"4/A","original_submission_date":"2017-12-15"}},{"id":4120014,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-28T18:38:57.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":49,"price":23.9767,"value":1174.8583,"ownership":{"direct":false,"nature":"By Managed Account for Trustees of the University of Pennsylvania"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On December 15, 2017, the Reporting Persons inadvertently reported that these shares were purchased for the account of Gallopavo, LP.  As correctly noted on this amendment, the shares were purchased for a managed account for Trustees of the University of Pennsylvania.  Gallopavo, LP has not engaged in trades since the report filed by the Reporting Persons on June 23, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range.  The actual prices for these transactions range from $23.97 to $23.99 inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":20031,"source":{"system":"sec-edgar","filing":"0001140361-17-047643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047643/form4.xml","form_type":"4/A","original_submission_date":"2017-12-15"}},{"id":4120013,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-28T18:38:57.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":19982,"price":24.8838,"value":497228.0916,"ownership":{"direct":false,"nature":"By Managed Account for Trustees of the University of Pennsylvania"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On December 15, 2017, the Reporting Persons inadvertently reported that these shares were purchased for the account of Gallopavo, LP.  As correctly noted on this amendment, the shares were purchased for a managed account for Trustees of the University of Pennsylvania.  Gallopavo, LP has not engaged in trades since the report filed by the Reporting Persons on June 23, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range.  The actual prices for these transactions range from $24.08 to $25.08 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":19982,"source":{"system":"sec-edgar","filing":"0001140361-17-047643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000114036117047643/form4.xml","form_type":"4/A","original_submission_date":"2017-12-15"}},{"id":4130037,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-14","kind":"purchase","acquired":true,"shares":37492,"price":24.6528,"value":924282.7776,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":431155,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130036,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":148,"price":23.9767,"value":3548.5516,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":393663,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130035,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":59982,"price":24.8838,"value":1492580.0916,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":393515,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130034,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-14","kind":"purchase","acquired":true,"shares":6245,"price":24.6528,"value":153956.736,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":103185,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130033,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":25,"price":23.9767,"value":599.4175,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":96940,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130032,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":9990,"price":24.8838,"value":248589.162,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":96915,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130031,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-14","kind":"purchase","acquired":true,"shares":19672,"price":24.6528,"value":484969.8816,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":748253,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130030,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":78,"price":23.9767,"value":1870.1826,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":728581,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130029,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":31471,"price":24.8838,"value":783118.0698,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":728503,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130028,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-14","kind":"purchase","acquired":true,"shares":14866,"price":24.6528,"value":366488.5248,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":477457,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130027,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":49,"price":23.9767,"value":1174.8583,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":462591,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4130026,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-12-15T18:38:49.000Z","date":"2017-12-13","kind":"purchase","acquired":true,"shares":19982,"price":24.8838,"value":497228.0916,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive.  The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP.  The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":462542,"source":{"system":"sec-edgar","filing":"0000905148-17-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000939/form4.xml","form_type":"4"}},{"id":4273287,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":110640,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":110640},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273286,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":33656,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC - Series A"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":33656},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273285,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":386285,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":386285},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273284,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":211708,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":211708},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273283,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":110640,"price":25,"value":2766000.0,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Class B common stock were acquired in a private transaction with another Class B shareholder pursuant to a purchase agreement dated June 22, 2017 (the \"Private Transaction\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":110640,"derivative":{"underlying":"Class A Common Stock","underlying_shares":110640},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273282,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":33656,"price":25,"value":841400.0,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC - Series A"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Class B common stock were acquired in a private transaction with another Class B shareholder pursuant to a purchase agreement dated June 22, 2017 (the \"Private Transaction\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":33656,"derivative":{"underlying":"Class A Common Stock","underlying_shares":33656},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273281,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":386285,"price":25,"value":9657125.0,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Class B common stock were acquired in a private transaction with another Class B shareholder pursuant to a purchase agreement dated June 22, 2017 (the \"Private Transaction\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":386285,"derivative":{"underlying":"Class A Common Stock","underlying_shares":386285},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273280,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":211708,"price":25,"value":5292700.0,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Class B common stock were acquired in a private transaction with another Class B shareholder pursuant to a purchase agreement dated June 22, 2017 (the \"Private Transaction\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":211708,"derivative":{"underlying":"Class A Common Stock","underlying_shares":211708},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273279,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":355591,"price":25,"value":8889775.0,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Class B common stock were acquired in a private transaction with another Class B shareholder pursuant to a purchase agreement dated June 22, 2017 (the \"Private Transaction\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":993929,"derivative":{"underlying":"Class A Common Stock","underlying_shares":355591},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273278,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B Common Stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":102120,"price":25,"value":2553000.0,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares of Class B common stock were acquired in a private transaction with another Class B shareholder pursuant to a purchase agreement dated June 22, 2017 (the \"Private Transaction\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Class B common stock are convertible into Class A common stock on a one-for-one basis at the holder's election at any time for no additional consideration, and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":114946,"derivative":{"underlying":"Class A Common Stock","underlying_shares":102120},"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273277,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":110640,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":110640,"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273276,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":33656,"ownership":{"direct":false,"nature":"By Blackwell Partners LLC - Series A"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":86925,"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}},{"id":4273275,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":91372,"kind":"organization","name":"CPMG Inc","position":1,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2017-06-23T17:54:43.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":386285,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Because none of Blackwell Partners LLC - Series A, Gallopavo, LP, Roadrunner Fund, LP and Killdeer Fund, LP were holders of shares of Class B common stock at the time of the Private Transaction, then, pursuant to Section 4.4(b) of the Issuer's Thirteenth Amended and Restated Certificate of Incorporation, these shares of Class B common stock automatically convert into shares of Class A common stock in connection with the Private Transaction, on a one-for-one basis and for no additional consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the investment manager of each of: Killdeer Fund, LP; Blackwell Partners LLC - Series A; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners, LP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":697032,"source":{"system":"sec-edgar","filing":"0000905148-17-000624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000090514817000624/form4.xml","form_type":"4"}}],"next_cursor":"2017-06-23T17:54:43.000000Z,4273275"}